| Literature DB >> 25846235 |
Maria Gamella1, Nataliia Guz, José M Pingarrón, Roshanak Aslebagh, Costel C Darie, Evgeny Katz.
Abstract
A bioelectronic system composed of two modified electrodes, one activated in the presence of ketone bodies, a biomarker of diabetic ketoacidosis, and another releasing insulin upon receiving a signal, was designed and tested in vitro to operate as a Sense-and-Act device. The functional integration of biomarker-sensing and insulin-releasing electrodes represents a step to a theranostic system with autonomous operation.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25846235 DOI: 10.1039/c5cc01498k
Source DB: PubMed Journal: Chem Commun (Camb) ISSN: 1359-7345 Impact factor: 6.222